DK405887A - Vaevplasminogenaktivatorholdig kombination - Google Patents

Vaevplasminogenaktivatorholdig kombination

Info

Publication number
DK405887A
DK405887A DK405887A DK405887A DK405887A DK 405887 A DK405887 A DK 405887A DK 405887 A DK405887 A DK 405887A DK 405887 A DK405887 A DK 405887A DK 405887 A DK405887 A DK 405887A
Authority
DK
Denmark
Prior art keywords
wave
plasminogen activator
containing combination
combination
plasminogen
Prior art date
Application number
DK405887A
Other languages
English (en)
Other versions
DK163639B (da
DK405887D0 (da
DK163639C (da
Inventor
Bredan Joseph Richard Whittle
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10602253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK405887(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK405887D0 publication Critical patent/DK405887D0/da
Publication of DK405887A publication Critical patent/DK405887A/da
Publication of DK163639B publication Critical patent/DK163639B/da
Application granted granted Critical
Publication of DK163639C publication Critical patent/DK163639C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK405887A 1986-08-05 1987-08-04 Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper DK163639C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868619098A GB8619098D0 (en) 1986-08-05 1986-08-05 Combination
GB8619098 1986-08-05

Publications (4)

Publication Number Publication Date
DK405887D0 DK405887D0 (da) 1987-08-04
DK405887A true DK405887A (da) 1988-02-06
DK163639B DK163639B (da) 1992-03-23
DK163639C DK163639C (da) 1992-08-17

Family

ID=10602253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK405887A DK163639C (da) 1986-08-05 1987-08-04 Synergistisk farmaceutisk blanding af vaevsplasminogenaktivator og et prostaglandin, farmaceutisk praeparat indeholdende blandingen samt anvendelse af blandingen til fremstilling af et laegemiddel mod blodpropper

Country Status (10)

Country Link
US (1) US4839169A (da)
EP (1) EP0257859B1 (da)
JP (1) JPS63115823A (da)
AU (1) AU589283B2 (da)
CA (1) CA1297010C (da)
DE (1) DE3773805D1 (da)
DK (1) DK163639C (da)
GB (1) GB8619098D0 (da)
NZ (1) NZ221328A (da)
ZA (1) ZA875755B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen
EP0299376A3 (en) * 1987-07-13 1990-01-24 William Elson Shell Prostanoid compositions and methods for reducing blood vessel dysfunction
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
WO1992011866A1 (en) * 1991-01-14 1992-07-23 Duke University LAMININ SEQUENCE AS tPA ACTIVATOR
JP3559559B2 (ja) * 1992-06-03 2004-09-02 ジェネンテク，インコーポレイテッド 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158667A (en) * 1976-02-04 1979-06-19 The Upjohn Company 6-Keto PGF analogs
US4539333A (en) * 1976-05-11 1985-09-03 Burroughs Wellcome Co. Prostacyclin, methods of using and method of making
FR2469411A1 (fr) * 1979-11-15 1981-05-22 Science Union & Cie Nouveaux derives de la piperidylbenzimidazolinone, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
EP0112122B1 (en) * 1982-12-14 1991-08-28 South African Inventions Development Corporation Plasminogen activator
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
US4632919A (en) * 1984-09-27 1986-12-30 University Of Medicine & Dentistry Of N.J. Process for prolonging recalcification, prothrombin and thrombin times of plasma
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
NL8601354A (nl) * 1985-05-28 1986-12-16 Wellcome Found Nieuwe samenstelling.
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
DE3544663A1 (de) * 1985-12-13 1987-06-19 Schering Ag Thrombosebehandlung mit fibrinolytika und prostacyclinen

Also Published As

Publication number Publication date
DE3773805D1 (de) 1991-11-21
JPS63115823A (ja) 1988-05-20
EP0257859A2 (en) 1988-03-02
ZA875755B (en) 1989-03-29
EP0257859B1 (en) 1991-10-16
DK163639B (da) 1992-03-23
DK405887D0 (da) 1987-08-04
CA1297010C (en) 1992-03-10
JPH0460586B2 (da) 1992-09-28
GB8619098D0 (en) 1986-09-17
AU589283B2 (en) 1989-10-05
US4839169A (en) 1989-06-13
NZ221328A (en) 1990-09-26
EP0257859A3 (en) 1989-07-26
DK163639C (da) 1992-08-17
AU7657287A (en) 1988-02-11

Similar Documents

Publication Publication Date Title
AT399804B (de) Sportschuh
BR8701556A (pt) Prendedor
DK483488D0 (da) Peptidylaminodioler
DK161058C (da) Traefraeser
BR8705380A (pt) Triturador conico
FI88886B (fi) Munstycke foer laserbehandling
DK220387A (da) Aeion-sensorae
FI88825C (fi) Aktivt pansar
DK405887D0 (da) Vaevplasminogenaktivatorholdig kombination
NO171837C (no) Fartoey
DK30988A (da) 2-azetidinon-forbindelser
DK530087D0 (da) Thrombolytisk praeparat
AT386436B (de) Schachtsystem
DK1987A (da) Maltningsfremgangsmaade
KR860001345U (ko) 저주파 치료기
KR880000077U (ko) 제병기
KR850007445U (ko) 뺀찌
KR850005810U (ko) 뺀찌
IT8634934V0 (it) Pubblicazione turistico-culturale con ausilio audiofonico
BR8603832A (pt) Buzina piezoeletrica
IT8664806A0 (it) Easy
BR6602587U (pt) Disposicao introduzida em presilha
DK312086D0 (da) Katalytisk hydroformylering
SE8401349D0 (sv) Vagkraftverk
IT8667601A0 (it) Struttura frangionde

Legal Events

Date Code Title Description
PBP Patent lapsed